Table 3. Number of cost-effectiveness analyses comparing drug–drug interventions and/or drug-non active control.

	Alternatives
Interventions	Atorva	Fluva	Lova	Prava	Rosuva	Simva	Non-active
Atorvastatin	4*	2	0	0	1	2	12
Fluvastatin	0	0	0	1	0	0	4
Lovastatin	0	0	2*	0	0	0	3
Pravastatin	0	0	0	0	0	0	18
Rosuvastatin	1	0	0	0	0	3	6
Simvastatin	0	0	0	0	1	2*	13

^* Includes high-dose versus low-dose statin monotherapy and/or combination therapies.